Dr. Jacob Gantz, M.D
NPI: 1487048955
Total Payments
$2,025
2024 Payments
$1,015
Companies
21
Transactions
90
Medicare Patients
820
Medicare Billing
$87,662
Payment Breakdown by Category
Food & Beverage$1,945 (96.1%)
Education$79.35 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,945 | 89 | 96.1% |
| Education | $79.35 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $334.16 | 19 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $322.54 | 19 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $160.71 | 6 | $0 (2024) |
| Olympus America Inc. | $153.17 | 3 | $0 (2023) |
| ABBVIE INC. | $127.21 | 6 | $0 (2024) |
| Antares Pharma, Inc. | $125.71 | 5 | $0 (2024) |
| Boston Scientific Corporation | $120.08 | 2 | $0 (2024) |
| COLOPLAST CORP | $101.98 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $89.60 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $83.85 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,015 | 47 | Sumitomo Pharma America, Inc. ($287.88) |
| 2023 | $732.09 | 24 | Olympus America Inc. ($153.17) |
| 2022 | $237.31 | 17 | Astellas Pharma US Inc ($139.39) |
| 2021 | $40.41 | 2 | Astellas Pharma US Inc ($40.41) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: UROLOGY | ||||||
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Diagnostic Imaging | ||||||
| 09/19/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: UROLOGY | ||||||
| 08/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/29/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: UROLOGY | ||||||
| 07/18/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: UROLOGY | ||||||
| 06/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: UROLOGY | ||||||
| 05/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 557 | 750 | $124,026 | $61,081 |
| 2022 | 6 | 263 | 296 | $47,900 | $26,581 |
Total Patients
820
Total Services
1,046
Medicare Billing
$87,662
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 240 | $27,977 | $14,408 | 51.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 99 | $24,865 | $12,891 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 139 | $23,908 | $11,521 | 48.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 44 | 46 | $15,069 | $8,205 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $11,859 | $5,176 | 43.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $7,574 | $2,859 | 37.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $4,900 | $2,456 | 50.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $2,101 | $1,462 | 69.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 16 | 34 | $3,802 | $1,369 | 36.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 18 | $1,140 | $462.24 | 40.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 23 | 24 | $716.64 | $184.92 | 25.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 19 | 21 | $103.32 | $82.74 | 80.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 14 | $11.20 | $5.68 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 151 | $17,602 | $10,466 | 59.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 33 | 33 | $10,810 | $6,285 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 43 | $7,396 | $4,036 | 54.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $6,738 | $3,150 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,284 | $2,589 | 49.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 12 | 14 | $68.88 | $55.24 | 80.2% |
About Dr. Jacob Gantz, M.D
Dr. Jacob Gantz, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1487048955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Gantz, M.D has received a total of $2,025 in payments from pharmaceutical and medical device companies, with $1,015 received in 2024. These payments were reported across 90 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,945).
As a Medicare-enrolled provider, Gantz has provided services to 820 Medicare beneficiaries, totaling 1,046 services with total Medicare billing of $87,662. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Rochester, NY
- Active Since 03/23/2015
- Last Updated 03/23/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1487048955
Products in Payments
- GEMTESA (Drug) $287.88
- iTIND System (Device) $153.17
- Xtandi (Drug) $110.67
- XYOSTED (Drug) $105.07
- Myrbetriq (Drug) $103.73
- SpeediCath (Device) $101.98
- ADSTILADRIN (Biological) $89.60
- BOTOX (Biological) $88.90
- PROLARIS (Device) $85.20
- KEYTRUDA (Biological) $83.85
- INTERSTIM (Device) $81.72
- LoFric (Device) $77.28
- ORGOVYX (Drug) $49.88
- JELMYTO (Drug) $47.73
- XTANDI (Drug) $40.41
- ILLUCCIX (Drug) $39.13
- LUPRON DEPOT (Drug) $38.31
- ERLEADA (Drug) $36.91
- XIAFLEX (Biological) $35.16
- Bulkamid (Device) $31.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Rochester
Dr. Yucai Wang, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $1.1M
Student in an Organized Health Care Education/Training Program $1.1M
Kevin Perry, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $675,526
Student in an Organized Health Care Education/Training Program $675,526
Arjun Sebastian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $132,513
Student in an Organized Health Care Education/Training Program $132,513
Benjamin Tracy
Student in an Organized Health Care Education/Training Program — Payments: $112,594
Student in an Organized Health Care Education/Training Program $112,594
Dr. Vijay Agarwal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $105,512
Student in an Organized Health Care Education/Training Program $105,512
Mr. Timothy Brown, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $89,868
Student in an Organized Health Care Education/Training Program $89,868